Lamivudine treatment for fulminant hepatic failure due to acute exacerbation of chronic hepatitis B infection.
about
The efficacy and safety of Nucleos(t)ide analogues in patients with spontaneous acute exacerbation of chronic hepatitis B: a systematic review and meta-analysisSerum Glycopatterns as Novel Potential Biomarkers for Diagnosis of Acute-on-Chronic Hepatitis B Liver FailureAsian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update.The role of lamivudine and predictors of mortality in severe flare-up of chronic hepatitis B with jaundice.Predictors for early HBeAg loss during lamivudine therapy in HBeAg-positive chronic hepatitis B patients with acute exacerbationTreatment of chronic hepatitis B: case selection and duration of therapy.Meta-analysis of the short-term effects of lamivudine treatment for severe chronic hepatitis B.Anti-viral therapy in hepatitis B virus reactivation with acute-on-chronic liver failure.Antiviral activity of a nanoemulsion of polyprenols from ginkgo leaves against influenza A H3N2 and hepatitis B virus in vitro.Entecavir and lamivudine therapy for severe acute chronic hepatitis B.Virological efficacy of combination therapy with corticosteroid and nucleoside analogue for severe acute exacerbation of chronic hepatitis B.Management of hepatitis B virus-related acute liver failure.Influential factors of prognosis in lamivudine treatment for patients with acute-on-chronic hepatitis B liver failure.Lamivudine monotherapy for spontaneous severe acute exacerbation of chronic hepatitis B.Hepatitis B virus reactivation in a juvenile rheumatoid arthritis patient under treatment and its successful management: a complicated case.Benefit of lamivudine therapy and factors associated with clinical outcome in spontaneous severe acute exacerbation of chronic hepatitis B virus infection.Entecavir treatment prevents disease progression in hepatitis B virus-related acute-on-chronic liver failure: establishment of a novel logistical regression model.Safety and efficacy of lamivudine in patients with severe acute or fulminant hepatitis B, a multicenter experience.Prediction model of the progression of patients with acute deterioration of hepatitis B virus-related chronic liver disease to acute-on-chronic liver failure
P2860
Q28533788-2494E822-9C8F-490D-94F8-33D2EAE5C2E6Q30358956-040BEFEC-5FCA-41C4-88FB-48EA8E3E27A4Q30391932-00A69886-8E68-4947-BB7E-0E4D9F87ECC7Q33345288-02C69816-754B-4E70-BFFD-4390D90F2824Q34553545-681F3A0D-140D-4C08-BC7E-739EA9295DB7Q34619363-AE383D11-C05E-4C4D-80F4-F8EAB15C4F98Q34694495-1D76CDF3-8632-4E67-87E4-5E4D31560E20Q38383397-5DAB3CD2-E796-4BB9-AB20-D6A40F047A01Q38895341-648DF680-87AA-4CC1-8C7F-D3C608820FE4Q42110843-F1732C7B-B724-49E8-BA7D-21F5C26FFE48Q42223335-DF24BB0C-4DF7-4A4B-AEB4-5A88A69DA7EAQ42240045-4F5BEBEC-0F95-4E3E-AB8B-88140C12ADD2Q43227919-AD226807-DD85-4502-AB3F-A041D2D5CA25Q44043595-680ED9D0-60C2-414C-B27F-BD8416082A10Q44688947-04A7E42C-B772-42A7-BF98-EB045491DC84Q45163314-23CDC6BC-DB4B-4764-9145-3C9B1C7E5187Q45341253-7EEC4A18-E42B-4D4E-8C61-E8CEACE33DBEQ47212247-27E92D84-3A78-4411-B461-A8EB2CD181D2Q58706223-F52BBB78-6ED0-4F72-BBD5-1D99E57C944D
P2860
Lamivudine treatment for fulminant hepatic failure due to acute exacerbation of chronic hepatitis B infection.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Lamivudine treatment for fulmi ...... chronic hepatitis B infection.
@en
Lamivudine treatment for fulmi ...... chronic hepatitis B infection.
@nl
type
label
Lamivudine treatment for fulmi ...... chronic hepatitis B infection.
@en
Lamivudine treatment for fulmi ...... chronic hepatitis B infection.
@nl
prefLabel
Lamivudine treatment for fulmi ...... chronic hepatitis B infection.
@en
Lamivudine treatment for fulmi ...... chronic hepatitis B infection.
@nl
P2093
P2860
P1476
Lamivudine treatment for fulmi ...... chronic hepatitis B infection.
@en
P2093
P2860
P304
P356
10.1046/J.1365-2036.2001.01107.X
P407
P577
2001-11-01T00:00:00Z